Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells

Sue M. Firth*, Susan Fanayan, Diana Benn, Robert C. Baxter

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    46 Citations (Scopus)

    Abstract

    Insulin-like growth factor binding protein-3 (IGFBP-3) has antiproliferative effects in many cell types but paradoxical growth stimulation has also been reported. In early passages following transfection of T47D breast cancer cells with IGFBP-3 cDNA, the proliferation rate and serum-stimulated DNA synthesis were significantly reduced compared to control cells. Cell cycle analysis indicated that growth-inhibited IGFBP-3-producing cells accumulated in G1 phase. After several passages, the transfected cells became resistant to the inhibitory effects of IGFBP-3 and showed transiently enhanced proliferation rates despite an increased IGFBP-3 concentration in the medium. IGFBP-3 proteolysis did not account for its decreased antiproliferative activity in resistant cells. We hypothesize that development of resistance to the antiproliferative action of IGFBP-3 might be an important step in the malignant progression of breast cancer cells.

    Original languageEnglish
    Pages (from-to)325-329
    Number of pages5
    JournalBiochemical and Biophysical Research Communications
    Volume246
    Issue number2
    DOIs
    Publication statusPublished - 19 May 1998

    Fingerprint

    Dive into the research topics of 'Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells'. Together they form a unique fingerprint.

    Cite this